Healthcare · Profile from Healthcare Research Companion
VillageMD (Village Practice Management Company, LLC)
The Chicago company founded in 2013 to put independent primary care doctors into value-based contracts, which became the vehicle for Walgreens' biggest strategic bet: roughly $9.7bn of Walgreens money (~$1bn in 2020, ~$5.2bn in 2021, ~$3.5bn in 2022; ~$12.2bn including Cigna's ~$2.5bn), a plan for 1,000 "Village Medical at Walgreens" clinics, and the ~$8.9bn purchase of Summit Health–CityMD in January 2023. Within two years the plan reversed. Clinics closed by the hundred, VillageMD left Florida, Indiana, Rhode Island and other markets, Walgreens took a ~$12.4bn pre-tax impairment in fiscal 2024 (~$5.8bn attributable to Walgreens) and ~$3.0bn more in fiscal 2025, Cigna lost ~$2.7bn, and co-founder Tim Barry left in late 2024. When Sycamore Partners took Walgreens private in August 2025, VillageMD was split off as a standalone business to be sold piece by piece: Texas clinics to Harbor Health (2025 and 2026) and Summit Health's New Jersey operations to Horizon Blue Cross Blue Shield (agreed October 2026, pending).
At a glance
- Founded
- 2013, with early operations in Houston, Texas (first clinic partner) and headquarters in Chicago, Illinois
- Founders
- Tim Barry (CEO; former Anthem/health-plan executive, reported), Clive Fields, MD (Houston primary care physician; chief medical officer) and Paul Martino (ex-Cigna and Anthem clinical strategy executive; chief growth officer)
- Headquarters
- Chicago, Illinois
- Ownership / structure
- Venture-backed private company (Oak HC/FT, Athyrium, Kinnevik and others) 2013–2020; Walgreens Boots Alliance minority investor from July 2020, majority owner (~63%) from October 2021, ~53% after the Summit deal (January 2023), with Cigna/Evernorth as a large minority holder; Walgreens also became VillageMD's senior secured lender. Since August 28, 2025 a standalone company held by Sycamore Partners' Walgreens structure, with Walgreens' former shareholders holding a contingent right of up to $3.00/share tied to VillageMD monetization
- Leadership (2026)
- Jim Murray, interim CEO since late November 2024 (ex-Centene, Magellan, Humana; joined as COO in April 2024); permanent CEO not confirmed (verify)
- Segment and buyer
- Provider: owned and affiliated primary care (Village Medical), multispecialty care (Summit Health) and urgent care (CityMD). Payers: Medicare Advantage and Medicare (MSSP and CMMI models), commercial insurers, Medicaid, and fee-for-service patients
- Scale
- Peak (early 2023): 680+ provider locations in 26 markets after Summit (company); ~200+ Village Medical at Walgreens clinics at peak (approximate). By the Sycamore close (August 2025) ~90 co-located Walgreens clinics (Forbes, reported); after the 2026 Houston sale, Village Medical kept ~17 clinics in Georgia, 2 in Kentucky and 12 Houston practices (company spokesperson, October 2026)
- Revenue
- Never published separately. Expected to exceed ~$1bn in 2021 (company, reported); Walgreens' US Healthcare segment, of which VillageMD was the largest part, reported ~$6.6bn of sales in fiscal 2023 (Walgreens, approximate)
- Capital raised / valuation
- Angel funding ~$4m (2013); Series A ~$36m (Oak HC/FT, 2015); ~$80m (Athyrium, January 2018); Series B $100m (Kinnevik, September 2019); Walgreens ~$1bn (July 2020: ~$250m equity plus ~$750m convertible debt); Walgreens ~$5.2bn (October 2021, to ~63%); Summit deal financed with ~$3.5bn from Walgreens and ~$2.5bn from Cigna/Evernorth plus debt. Walgreens later lent ~$3.4bn of senior secured debt (as of February 2025, with high paid-in-kind interest, reported)
- Signature moves (incl. failures)
- Independent-practice value-based model (2013); Walgreens $1bn and co-located clinics (2020); Walgreens majority stake and 1,000-clinic target (2021); Summit Health–CityMD ~$8.9bn (2023); peak expansion including Starling Physicians (2023); market exits and closures (2023–24); Walgreens and Cigna impairments and CEO exit (2024); Sycamore separation and Harbor Health sales (2025–26); Summit New Jersey sale to Horizon (2026, pending)
8 strategic moves analysed
Each one gets a full strategy file in the companion: context, the decision, the financing, what happened, and the lesson.
2013
Founding and Independent Practice Model
Founding / business model
2020
Walgreens 1B Investment and CoLocated Clinics
Partnership / strategic investment
2021
Walgreens Majority Stake and 1000 Clinic Plan
Acquisition (majority stake by a strategic investor)
2022
Summit Health CityMD Acquisition
Acquisition
2023
Starling and Peak Expansion
Acquisition / expansion
2024
Impairments Cigna Loss and CEO Exit
Write-down / leadership change / ownership review
2024
Market Exits and Clinic Closures
Restructuring (market exits, closures, divestitures)
2025
Sycamore Separation and Asset Sales
Divestiture / ownership change (separation from Walgreens; sale of clinic groups and regional businesses)